News

July 28, 2021

Hapbee Users Log Over 1 Million Hours of Use for Sleep, Focus and Alertness Signals

Read More

March 17, 2021

EMulate Therapeutics to Participate in the Venture Summit \ Virtual Connect West on March 17 at 12pm PST

Read More

March 17, 2021

EMulate Therapeutics: Ushering in a New Era in Non-Invasive Cancer Therapy

Read More

December 30, 2020

A Medical Technology That Has The Highest Potential Over Any We Follow

Read More

December 18, 2020

Hapbee Commences Trading on the Frankfurt Exchange Under the Symbol “HA1”

Read More

December 17, 2020

Hapbee Announces Additions to Advisory Board

Read More

December 2, 2020

Hapbee Announces Launch of A Subscription-Based Wellbeing Wearable, Providing Members the Ability to Choose ‘How They Feel’

Read More

December 1, 2020

Hapbee Advances New Signals into Closed Beta Phase

Read More

November 13, 2020

Hapbee Announces Leadership Team Additions

Read More

November 5, 2020

Hapbee Provides Update on Recent Corporate Developments – Manufactured and Shipped Over 1,800 Hapbee Wearables to Early Adopters, Fulfilled All Orders from Successful Indiegogo Campaign, Released Public Beta Version of Smartphone App

Read More

Older »